Clinical Trial Results: Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ixazomib, lenalidomide, and dexamethasone with or without zoledronic acid after radiation in solitary osseous plasmacytoma; study termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Osseous Plasmacytoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ixazomib citrate (Ixazomib)
• Lenalidomide (lenalidomide)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Solitary Osseous Plasmacytoma | Phase 3 | Status: TERMINATED | Results posted: 2026-06-30